Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial

por Ito, Daisuke, Inoue, Kazuyuki, Saito, Daigo, Hamaguchi, Keiko, Kaneko, Kimie, Sumita, Takashi, Inukai, Kouichi, Inoue, Ikuo, Shimada, Akira
Publicado 2021

The Efficacy of Vildagliptin Concomitant With Insulin Therapy in Type 2 Diabetic Subjects

por Ito, Daisuke, Inoue, Kazuyuki, Kaneko, Kimie, Yanagisawa, Morifumi, Sumita, Takashi, Ikegami, Yuichi, Awata, Takuya, Ishida, Hitoshi, Katayama, Shigehiro, Inukai, Kouichi
Publicado 2015

Long-Term Effects of Ipragliflozin on Diabetic Nephropathy and Blood Pressure in Patients With Type 2 Diabetes: 104-Week Follow-up of an Open-Label Study

por Ito, Daisuke, Inoue, Kazuyuki, Sumita, Takashi, Hamaguchi, Keiko, Kaneko, Kimie, Yanagisawa, Morifumi, Inukai, Kouichi, Inoue, Ikuo, Noda, Mitsuhiko, Shimada, Akira
Publicado 2018